Minerva Neurosciences Stock News

Gainers Ranger Energy Services, Inc. (NYSE: RNGR) shares rose 44.8% to close at $4.46 on Thursday. Ampco-Pittsburgh Corporation (NYSE: AP) shares surged 35.6% to close at $3.20...

Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat unmet medical needs of central nervous system (CNS) disorders

Midway through trading Thursday, the Dow traded down 8.55% to 21539.88 while the NASDAQ fell 7.05% to 7391.26. The S&P also fell, dropping 7.63% to 2,532.15. South Korea...

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Principia Biopharma (PRNB), Constellation Pharmaceuticals

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Principia Biopharma

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ChemoCentryx (CCXI), Crinetics Pharmaceuticals (CRNX) and

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ChemoCentryx ( CCXI – Research Report ), Crinetics Pharmaceuticals ( CRNX – Research Report ) and T

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on TRACON Pharmaceuticals (TCON), Aduro BioTech (ADRO) and

Company confirms timing of expected top-line results from Phase 3 roluperidone trial in Q2 2020 Management to host conference call today at 8:30 a.m. Eastern Time WALTHAM,.